Published in Acta Vet Hung on January 01, 2000
Peptide neurotoxins from fish-hunting cone snails. Science (1985) 2.77
Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol (1993) 2.56
Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol (1992) 2.33
Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J Invest Dermatol (1999) 2.20
Phylogeny and nomenclature of the genus Talaromyces and taxa accommodated in Penicillium subgenus Biverticillium. Stud Mycol (2011) 1.98
Polyphasic taxonomy of Aspergillus section Fumigati and its teleomorph Neosartorya. Stud Mycol (2007) 1.90
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum (2000) 1.82
Aspergillus species identification in the clinical setting. Stud Mycol (2007) 1.81
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum (1999) 1.75
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis (2006) 1.70
Interstitial laser photocoagulation for the treatment of osteoid osteoma. J Bone Joint Surg Br (2000) 1.68
Endoluminal ultrasonography of the distal esophagus in systemic sclerosis. Gastroenterology (1993) 1.60
Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry (1987) 1.60
The current status of species recognition and identification in Aspergillus. Stud Mycol (2007) 1.55
Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem (2000) 1.55
Photodynamic therapy for cancer of the pancreas. Gut (2002) 1.51
Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-beta. Biochem Biophys Res Commun (1986) 1.51
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med (1994) 1.50
Diagnostic tools to identify black aspergilli. Stud Mycol (2007) 1.49
The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the differential diagnosis of cold thyroid nodules. Eur J Nucl Med (1999) 1.47
Two new aflatoxin producing species, and an overview of Aspergillus section Flavi. Stud Mycol (2011) 1.46
Phenotypic and genotypic analysis of variability in Aspergillus fumigatus. J Clin Microbiol (1995) 1.46
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum (2001) 1.42
Pathogenesis of scleroderma. Collagen. Rheum Dis Clin North Am (1996) 1.39
Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol (2000) 1.38
Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. J Cell Physiol (2000) 1.36
Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J Biol Chem (2001) 1.36
Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor beta 1. J Biol Chem (1994) 1.32
Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis (2007) 1.26
Polyphasic taxonomy of Aspergillus section Usti. Stud Mycol (2007) 1.26
New and revisited species in Aspergillus section Nigri. Stud Mycol (2011) 1.25
Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene (2000) 1.19
The species concept in Aspergillus: recommendations of an international panel. Stud Mycol (2007) 1.17
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum (1999) 1.16
Biodiversity of Aspergillus species in some important agricultural products. Stud Mycol (2007) 1.15
Serological and some pathological characteristics of Escherichia coli strains isolated from rabbits. Zentralbl Veterinarmed B (1982) 1.15
A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate. Oncogene (2009) 1.13
Transforming growth factor-beta stimulation of lung fibroblast prostaglandin E2 production. J Biol Chem (1989) 1.10
Immunochemical detection of ochratoxin A in black Aspergillus strains. Mycopathologia (1996) 1.09
Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J Invest Dermatol (1990) 1.09
Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum (2000) 1.09
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Arthritis Rheum (1998) 1.05
Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta. Exp Cell Res (2000) 1.04
Characterization of virulence plasmid types in Rhodococcus equi isolates from foals, pigs, humans and soil in Hungary. Vet Microbiol (2002) 1.04
Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta. J Clin Invest (1994) 1.03
The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan. Eur J Surg Oncol (2011) 0.99
Nesfatin-1 exerts long-term effect on food intake and body temperature. Int J Obes (Lond) (2012) 0.99
Modulation of human alpha1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro. Gene (1998) 0.98
A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease. J Rheumatol (1998) 0.98
Gastric antral vascular ectasia (watermelon stomach) in patients with systemic sclerosis. Arthritis Rheum (1996) 0.98
Polyphasic taxonomy of the heat resistant ascomycete genus Byssochlamys and its Paecilomyces anamorphs. Persoonia (2009) 0.98
Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression. J Cell Physiol (1998) 0.98
New taxa in Aspergillus section Usti. Stud Mycol (2011) 0.97
High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J Rheumatol (1998) 0.96
Biochemical and serological properties of Actinobacillus pleuropneumoniae biotype 2 strains isolated from swine. Vet Microbiol (1989) 0.96
The fate of Staphylococcal exfoliatin in newborn and adult mice. Br J Dermatol (1976) 0.96
Characterisation of cellobiose dehydrogenases from the white-rot fungi Trametes pubescens and Trametes villosa. Appl Microbiol Biotechnol (2003) 0.96
New species in Aspergillus section Terrei. Stud Mycol (2011) 0.95
What is a species in Aspergillus? Med Mycol (2009) 0.95
Opposing regulation of interleukin-8 and NF-kappaB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor. Int J Immunopathol Pharmacol (2004) 0.94
Positive regulation of human alpha 1 (I) collagen promoter activity by transcription factor Sp1. Gene (1995) 0.94
Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis. Arthritis Rheum (1998) 0.94
Molecular and phenotypic characterization of Aspergillus japonicus and Aspergillus aculeatus strains with special regard to their mitochondrial DNA polymorphisms. Antonie Van Leeuwenhoek (1997) 0.94
Beta-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats. Neurosci Lett (1998) 0.94
Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum (2001) 0.93
Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders. Arch Dermatol (1993) 0.93
The induction of accelerated murine amyloid with human splenic extract. Probable role of amyloid enhancing factor. Virchows Arch B Cell Pathol Incl Mol Pathol (1986) 0.93
Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. J Rheumatol (2000) 0.92
Aspergillus acidus from Puerh tea and black tea does not produce ochratoxin A and fumonisin B2. Int J Food Microbiol (2009) 0.91
Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol (1993) 0.91
Pulmonary function and gastroesophageal reflux in systemic sclerosis. Ann Intern Med (1994) 0.90
Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status. Respir Med (1996) 0.90
[Imperforate hymen: one diagnosis can hide another]. Arch Pediatr (2010) 0.90
Coagglutination test for serotyping Pasteurella haemolytica. J Clin Microbiol (1996) 0.90
Selective inhibition of collagen gene expression in fibroblasts by an interferon-gamma transgene. Exp Lung Res (1999) 0.89
Technetium-99m-sestamibi/pertechnetate subtraction scintigraphy vs ultrasonography for preoperative localization in primary hyperparathyroidism. Eur Radiol (2001) 0.88
Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma. J Cell Physiol (1999) 0.87
Modulation of basal expression of the human alpha1(I) procollagen gene (COL1A1) by tandem NF-1/Sp1 promoter elements in normal human dermal fibroblasts. Matrix Biol (1998) 0.86
Mutations of serine 236-237 and tyrosine 302 residues in the human lipoxin A4 receptor intracellular domains result in sustained signaling. Biochemistry (2000) 0.86
Elevated expression of the genes for transforming growth factor-beta 1 and type VI collagen in diffuse fasciitis associated with the eosinophilia-myalgia syndrome. J Invest Dermatol (1991) 0.86
Comparison of ultrasonography, bovine pregnancy-specific protein B, and bovine pregnancy-associated glycoprotein 1 tests for pregnancy detection in dairy cows. Theriogenology (1998) 0.85
Bonding of amalgam filling to tooth cavity with adhesive resin. Dent Mater J (1986) 0.85
Isolation and characterization of Actinobacillus seminis strains from ovine semen samples and epididymitis. Zentralbl Veterinarmed B (1987) 0.85
Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: is more than seven-thousand rad target dose necessary? Thyroid (1999) 0.85
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial. Rheumatology (Oxford) (2001) 0.85
Sarcoidosis in systemic sclerosis: report of 7 cases. J Rheumatol (1995) 0.85
Molecular polymorphism and phenotypic variation in Aspergillus carbonarius. Antonie Van Leeuwenhoek (1996) 0.84
Sexual and vegetative compatibility genes in the aspergilli. Stud Mycol (2007) 0.84
Design of potent cyclic gonadotropin releasing hormone antagonists. J Med Chem (1988) 0.84
Corticosteroid-induced juxta-articular adiposis dolorosa. Arch Dermatol (1991) 0.84
Peripheral neuropathy associated with eosinophilia-myalgia syndrome. Ann Neurol (1990) 0.83
Elevated levels of eosinophil major basic protein in the sera of patients with systemic sclerosis. Arthritis Rheum (1995) 0.83
Characterisation of a new serotype of P haemolytica isolated in Hungary. Res Vet Sci (1988) 0.83
Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts. Clin Exp Immunol (2000) 0.83
Ochratoxin degradation and adsorption caused by astaxanthin-producing yeasts. Food Microbiol (2006) 0.82
The relationship of thoracic lymphadenopathy to pulmonary interstitial disease in diffuse and limited systemic sclerosis: CT findings. AJR Am J Roentgenol (1996) 0.82
In-vitro activity of cefetamet (Ro 15-8074) compared with other oral agents. J Antimicrob Chemother (1989) 0.82
Serotonin-immunoreactive cells in the superior cervical ganglion of the rat. Evidence for the existence of separate serotonin- and catecholamine-containing small ganglionic cells. Brain Res (1981) 0.82
Biophysical studies with high-energy argon ions 2. Determinations of the relative biological effectiveness, the oxygen enhancement ratio, and the cell cycle response. Radiat Res (1977) 0.82
Plasma levels of TNF and IL-6 following induction of acute pancreatitis and pentoxifylline treatment in rats. Acta Chir Hung (1997) 0.81